PSEN2 and Alzheimer disease: In 2013, we have identified and validated by both approaches, two additional PK transcriptional targets linked to Alzheimer’s disease (AD), namely, presenilins 1 (PS1) and 2 (PS2) (Duplan et al., 2013b).